Crystal structure of metronidazolium tetra­chlorido­aurate(III)

Patrick J Quinlivan; Ja-Shin Wu; Rita K Upmacis

doi:10.1107/S2056989015010798

. 2015 Jun 17;71(Pt 7):810–812. doi: 10.1107/S2056989015010798

Crystal structure of metronidazolium tetrachloridoaurate(III)

Patrick J Quinlivan ^a, Ja-Shin Wu ^b, Rita K Upmacis ^b,^*

PMCID: PMC4518979 PMID: 26279873

Metronidazole (MET) reacts with HAuCl₄·H₂O to give metronidazolium tetrachloridoaurate(III), [H(MET)][AuCl₄], in which the cation and anion are linked via an O—H⋯Cl hydrogen-bonding interaction.

Keywords: crystal structure, gold, metronidazole, flagyl, tetrachloridoaurate(III), O—H⋯Cl hydrogen bonding

Abstract

Metronidazole (MET) [systematic names: 1-(2-hydroxyethyl)-2-methyl-5-nitro-1H-imidazole and 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethanol] is a medication that is used to treat infections from a variety of anaerobic organisms. As with other imidazole derivatives, metronidazole is also susceptible to protonation. However, there are few reports of the structures of metronidazolium derivatives. In the title compound, (C₆H₁₀N₃O₃)[AuCl₄] [systematic name: 1-(2-hydroxyethyl)-2-methyl-5-nitro-1H-imidazol-3-ium tetrachloridoaurate(III)], the asymmetric unit consists of a metronidazolium cation, [H(MET)]⁺, and a tetrachloridoaurate(III) anion, [AuCl₄]⁻, in which the Au^III ion is in a slightly distorted square-planar coordination environment. In the cation, the nitro group is essentially coplanar with the imidazole ring, as indicated by an O N—C=C torsion angle of −0.2 (4)°, while the hydroxyethyl group is in a coiled conformation, with an O(H)—C—C—N torsion angle of 62.3 (3)°. In the crystal, the anion and cation are linked by an intermolecular O—H⋯Cl hydrogen bond. In addition, the N—H group of the metronidazolium ion serves as a hydrogen-bond donor to the O atom of the hydroxyethyl group of a symmetry-related molecule, leading to the formation of chains along [010].

Chemical context

Metronidazole (MET), marketed as flagyl, and also known by the systematic names 1-(2-hydroxyethyl)-2-methyl-5-nitro-1H-imidazole and 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethanol, is a medication that has been used for the treatment of parasitic infections, such as trichomoniasis, amoebiasis and giardiasis, and is also effective against anaerobic bacteria (Freeman et al., 1997 ▸; Miljkovic et al., 2014 ▸; Soares et al., 2012 ▸; Samuelson, 1999 ▸; Lofmark et al., 2010 ▸; Contreras et al., 2009 ▸). Metronidazole possesses a variety of functional groups, and the two-coordinate nitrogen atom of the imidazole ring has been shown to be an effective ligand for a variety of metals (Contreras et al., 2009 ▸). This nitrogen atom is also susceptible to protonation, but there are few structures of metronidazolium derivatives reported in the literature (Yang, 2008 ▸; Wang et al., 2010 ▸). We describe herein the structure of metronidazolium tetrachloridoaurate(III), which is obtained by the addition of MET to HAuCl₄.

Structural commentary

The asymmetric unit of [H(MET)][AuCl₄] consists of a metronidazolium cation, [H(MET)]⁺, hydrogen-bonded to a square-planar tetrachloridoaurate(III) anion, [AuCl₄]⁻, by an O—H⋯Cl hydrogen bond as illustrated in Fig. 1 ▸. The O3⋯Cl3 distance of 3.169 (2) Å is comparable to the values in other tetrachloridoaurate(III) derivatives that exhibit O—H⋯Cl hydrogen bonds. As an illustration, bis{2-[(2-hydroxyethyl)iminomethyl]phenolato}gold(III) tetrachloridoaurate(III) possesses an O—H⋯Cl hydrogen bond between a hydroxyethyl group and [AuCl₄]⁻, with an O(H)⋯Cl distance of 3.365 Å (Nockemann et al., 2007 ▸). For further reference, the average O⋯Cl distance in compounds that have O—H⋯Cl interactions is 3.196 (3) Å (Steiner, 2002 ▸). The nitro group is almost coplanar with the imidazole ring, as indicated by an O1—N3—C2—C1 torsion angle of −0.2 (4)°, while the hydroxyethyl group exhibits an O3—C6—C5—N2 torsion angle of 62.3 (3)°, describing a coiled conformation. graphic file with name e-71-00810-scheme1.jpg

The asymmetric unit of the title compound, shown with 20% probability displacement ellipsoids. The O3—H3⋯Cl3 hydrogen bond is shown as an open bond.

Supramolecular features

In the crystal, the N—H group of the metronidazolium ion serves as a hydrogen-bond donor to the oxygen atom of the hydroxyethyl group of a symmetry-related molecule, forming a chain along [010] in which each O—H group is O—H⋯Cl hydrogen bonded to a [AuCl₄]⁻ ion (Table 1 ▸ and Fig. 2 ▸). The N⋯O distance of 2.729 (3) Å associated with the hydrogen bond is comparable to that observed for metronidazole [2.816 (2) Å] (Blaton et al., 1979 ▸; Galván-Tejada et al., 2002 ▸). However, an important difference between the hydrogen bonds in metronidazole and metronidazolium is that the alcohol O—H group is the hydrogen-bond donor for metronidazole (i.e. O—H⋯N), while the N—H group is the hydrogen-bond donor for metronidazolium (i.e. N—H⋯O).

Table 1. Hydrogen-bond geometry (, ).

DHA	DH	HA	D A	DHA
N1H01O3ⁱ	0.94(4)	1.81(4)	2.729(3)	166(3)
O3H3Cl3	0.67(4)	2.54(4)	3.169(2)	158(4)

Open in a new tab

Symmetry code: (i) Inline graphic .

Part of the crystal structure showing a hydrogen-bonded chain (open bonds) along [010].

Database survey

Metronidazolium derivatives that feature other counter-ions, e.g. 3-carboxy-4-hydroxybenzenesulfonate and perchlorate have been reported (Yang, 2008 ▸; Wang et al., 2010 ▸), as have a variety of tetrachloridoaurate(III) complexes (Johnson & Steed, 1998 ▸; Pluzhnik-Gladyr et al., 2014 ▸; Fazaeli et al., 2010 ▸).

Synthesis and crystallization

Crystals of composition [H(MET)][AuCl₄] were obtained by combining HAuCl₄·H₂O (0.12 mmol) with MET (0.20 mmol) in MeOH (2 ml), followed by evaporation of MeOH, and crystallization from Et₂O.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. H atoms bonded to C atoms were refined with a riding model, with C—H = 0.95–0.99 Å and U _iso(H) = 1.2U _eq(C) or 1.5U _eq(C_methyl). H atoms bonded to N and O atoms were refined independently with isotropic displacement parameters.

Table 2. Experimental details.

Crystal data
Chemical formula	(C₆H₁₀N₃O₃)[AuCl₄]
M _r	510.94
Crystal system, space group	Monoclinic, P2₁/n
Temperature (K)	130
a, b, c ()	7.324(2), 11.972(4), 15.667(5)
()	94.384(4)
V (³)	1369.6(8)
Z	4
Radiation type	Mo K
(mm¹)	11.52
Crystal size (mm)	0.23 0.04 0.02

Data collection
Diffractometer	Bruker APEXII CCD
Absorption correction	Multi-scan (SADABS; Bruker, 2013 ▸)
T _min, T _max	0.426, 0.746
No. of measured, independent and observed [I > 2(I)] reflections	22024, 4214, 3673
R _int	0.041
(sin /)_max (¹)	0.718

Refinement
R[F ² > 2(F ²)], wR(F ²), S	0.021, 0.045, 1.16
No. of reflections	4214
No. of parameters	163
H-atom treatment	H atoms treated by a mixture of independent and constrained refinement
_max, _min (e ³)	1.30, 1.22

Open in a new tab

Computer programs: APEX2 and, SAINT (Bruker, 2013 ▸), SHELXS97 and SHELXTL (Sheldrick, 2008 ▸), SHELXL2014 (Sheldrick, 2015 ▸).

Supplementary Material

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015010798/lh5766sup1.cif

e-71-00810-sup1.cif^{(658.8KB, cif)}

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015010798/lh5766Isup3.hkl

e-71-00810-Isup3.hkl^{(335.9KB, hkl)}

CCDC reference: 1404845

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

RKU would like to thank Pace University for research support. Gerard Parkin (Columbia University) is thanked for helpful discussions.

supplementary crystallographic information

Crystal data

(C₆H₁₀N₃O₃)[AuCl₄]	F(000) = 952
M_r = 510.94	D_x = 2.478 Mg m⁻³
Monoclinic, P2₁/n	Mo Kα radiation, λ = 0.71073 Å
a = 7.324 (2) Å	Cell parameters from 9874 reflections
b = 11.972 (4) Å	θ = 2.6–30.6°
c = 15.667 (5) Å	µ = 11.52 mm⁻¹
β = 94.384 (4)°	T = 130 K
V = 1369.6 (8) Å³	Plate, yellow
Z = 4	0.23 × 0.04 × 0.02 mm

Open in a new tab

Data collection

Bruker APEXII CCD diffractometer	3673 reflections with I > 2σ(I)
φ and ω scans	R_int = 0.041
Absorption correction: multi-scan (SADABS; Bruker, 2013)	θ_max = 30.7°, θ_min = 2.1°
T_min = 0.426, T_max = 0.746	h = −10→10
22024 measured reflections	k = −17→17
4214 independent reflections	l = −22→22

Open in a new tab

Refinement

Refinement on F²	0 restraints
Least-squares matrix: full	Hydrogen site location: mixed
R[F² > 2σ(F²)] = 0.021	H atoms treated by a mixture of independent and constrained refinement
wR(F²) = 0.045	w = 1/[σ²(F_o²) + (0.0129P)²] where P = (F_o² + 2F_c²)/3
S = 1.16	(Δ/σ)_max = 0.001
4214 reflections	Δρ_max = 1.30 e Å⁻³
163 parameters	Δρ_min = −1.22 e Å⁻³

Open in a new tab

Special details

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.

Open in a new tab

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å²)

	x	y	z	U_iso*/U_eq
Au	0.36629 (2)	0.79983 (2)	0.58625 (2)	0.01868 (4)
Cl1	0.26070 (11)	0.84595 (7)	0.45047 (5)	0.03247 (17)
Cl2	0.44092 (10)	0.62541 (6)	0.54111 (5)	0.03012 (16)
Cl3	0.46029 (10)	0.75210 (6)	0.72389 (5)	0.02610 (15)
Cl4	0.29498 (10)	0.97418 (6)	0.63205 (5)	0.02831 (15)
O1	0.8047 (3)	0.7553 (2)	0.41611 (14)	0.0367 (5)
O2	0.9242 (3)	0.60835 (18)	0.47815 (14)	0.0331 (5)
O3	0.7450 (3)	0.55236 (18)	0.73360 (15)	0.0265 (5)
H3	0.684 (5)	0.591 (3)	0.719 (2)	0.042 (13)*
N1	0.8446 (3)	0.89061 (19)	0.65413 (15)	0.0175 (4)
H01	0.810 (5)	0.953 (3)	0.685 (2)	0.042 (10)*
N2	0.9387 (3)	0.72022 (17)	0.63739 (14)	0.0159 (4)
N3	0.8670 (3)	0.70319 (19)	0.47846 (15)	0.0223 (5)
C1	0.8127 (4)	0.8685 (2)	0.56913 (17)	0.0191 (5)
H1A	0.7604	0.9173	0.5261	0.023*
C2	0.8708 (3)	0.7626 (2)	0.55853 (17)	0.0158 (5)
C3	0.9200 (4)	0.8016 (2)	0.69521 (17)	0.0170 (5)
C4	0.9783 (4)	0.7982 (3)	0.78720 (19)	0.0272 (6)
H4A	0.9318	0.8643	0.8154	0.041*
H4B	1.1123	0.7972	0.7949	0.041*
H4C	0.9295	0.7307	0.8126	0.041*
C5	1.0107 (4)	0.6070 (2)	0.65912 (18)	0.0198 (5)
H5A	1.0863	0.6102	0.7142	0.024*
H5B	1.0904	0.5822	0.6145	0.024*
C6	0.8579 (4)	0.5230 (2)	0.66604 (18)	0.0227 (6)
H6A	0.7818	0.5199	0.6111	0.027*
H6B	0.9111	0.4479	0.6773	0.027*

Open in a new tab

Atomic displacement parameters (Å²)

	U¹¹	U²²	U³³	U¹²	U¹³	U²³
Au	0.01490 (5)	0.01746 (6)	0.02409 (6)	−0.00147 (4)	0.00416 (4)	−0.00253 (4)
Cl1	0.0438 (4)	0.0304 (4)	0.0234 (4)	0.0042 (3)	0.0037 (3)	−0.0009 (3)
Cl2	0.0286 (4)	0.0222 (3)	0.0400 (4)	0.0024 (3)	0.0057 (3)	−0.0092 (3)
Cl3	0.0255 (3)	0.0251 (3)	0.0272 (4)	0.0036 (3)	−0.0008 (3)	−0.0012 (3)
Cl4	0.0360 (4)	0.0193 (3)	0.0292 (4)	0.0033 (3)	0.0002 (3)	−0.0038 (3)
O1	0.0516 (15)	0.0375 (13)	0.0193 (11)	0.0047 (11)	−0.0090 (10)	−0.0008 (10)
O2	0.0468 (14)	0.0221 (11)	0.0309 (12)	0.0056 (10)	0.0058 (10)	−0.0077 (9)
O3	0.0250 (11)	0.0233 (11)	0.0327 (13)	0.0053 (9)	0.0109 (9)	0.0075 (9)
N1	0.0172 (10)	0.0152 (10)	0.0203 (11)	−0.0003 (9)	0.0023 (9)	−0.0003 (9)
N2	0.0146 (10)	0.0157 (10)	0.0175 (11)	0.0000 (8)	0.0021 (8)	0.0014 (8)
N3	0.0253 (12)	0.0233 (12)	0.0181 (12)	−0.0032 (10)	0.0010 (9)	−0.0019 (9)
C1	0.0217 (13)	0.0198 (13)	0.0157 (12)	0.0003 (10)	−0.0001 (10)	0.0012 (10)
C2	0.0184 (12)	0.0152 (11)	0.0138 (12)	−0.0023 (10)	0.0008 (9)	−0.0006 (9)
C3	0.0146 (12)	0.0188 (12)	0.0180 (13)	−0.0012 (10)	0.0038 (10)	0.0002 (10)
C4	0.0292 (16)	0.0355 (17)	0.0167 (14)	0.0031 (13)	0.0011 (12)	−0.0009 (12)
C5	0.0181 (12)	0.0170 (12)	0.0245 (14)	0.0051 (10)	0.0026 (10)	0.0064 (10)
C6	0.0254 (14)	0.0164 (13)	0.0271 (15)	0.0029 (11)	0.0072 (12)	0.0046 (11)

Open in a new tab

Geometric parameters (Å, º)

Au—Cl1	2.2752 (10)	N2—C5	1.485 (3)
Au—Cl4	2.2807 (9)	N3—C2	1.441 (3)
Au—Cl2	2.2844 (9)	C1—C2	1.351 (4)
Au—Cl3	2.2855 (10)	C1—H1A	0.9500
O1—N3	1.218 (3)	C3—C4	1.472 (4)
O2—N3	1.210 (3)	C4—H4A	0.9800
O3—C6	1.436 (3)	C4—H4B	0.9800
O3—H3	0.67 (4)	C4—H4C	0.9800
N1—C3	1.341 (3)	C5—C6	1.515 (4)
N1—C1	1.360 (3)	C5—H5A	0.9900
N1—H01	0.94 (4)	C5—H5B	0.9900
N2—C3	1.345 (3)	C6—H6A	0.9900
N2—C2	1.392 (3)	C6—H6B	0.9900

Cl1—Au—Cl4	90.14 (3)	N1—C3—N2	108.2 (2)
Cl1—Au—Cl2	90.27 (3)	N1—C3—C4	124.7 (2)
Cl4—Au—Cl2	179.36 (3)	N2—C3—C4	127.0 (2)
Cl1—Au—Cl3	177.66 (3)	C3—C4—H4A	109.5
Cl4—Au—Cl3	89.52 (3)	C3—C4—H4B	109.5
Cl2—Au—Cl3	90.09 (3)	H4A—C4—H4B	109.5
C6—O3—H3	108 (3)	C3—C4—H4C	109.5
C3—N1—C1	110.4 (2)	H4A—C4—H4C	109.5
C3—N1—H01	120 (2)	H4B—C4—H4C	109.5
C1—N1—H01	129 (2)	N2—C5—C6	111.8 (2)
C3—N2—C2	106.6 (2)	N2—C5—H5A	109.3
C3—N2—C5	124.1 (2)	C6—C5—H5A	109.3
C2—N2—C5	129.3 (2)	N2—C5—H5B	109.3
O2—N3—O1	125.9 (3)	C6—C5—H5B	109.3
O2—N3—C2	118.9 (2)	H5A—C5—H5B	107.9
O1—N3—C2	115.2 (2)	O3—C6—C5	111.1 (2)
C2—C1—N1	105.7 (2)	O3—C6—H6A	109.4
C2—C1—H1A	127.1	C5—C6—H6A	109.4
N1—C1—H1A	127.1	O3—C6—H6B	109.4
C1—C2—N2	109.1 (2)	C5—C6—H6B	109.4
C1—C2—N3	125.8 (2)	H6A—C6—H6B	108.0
N2—C2—N3	125.1 (2)

Open in a new tab

Hydrogen-bond geometry (Å, º)

D—H···A	D—H	H···A	D···A	D—H···A
N1—H01···O3ⁱ	0.94 (4)	1.81 (4)	2.729 (3)	166 (3)
O3—H3···Cl3	0.67 (4)	2.54 (4)	3.169 (2)	158 (4)

Open in a new tab

Symmetry code: (i) −x+3/2, y+1/2, −z+3/2.

References

Blaton, N. M., Peeters, O. M. & De Ranter, C. J. (1979). Acta Cryst. B35, 2465–2467.
Bruker (2013). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Contreras, R., Flores-Parra, A., Mijangos, E., Téllez, F., López-Sandoval, H. & Barba-Behrens, N. (2009). Coord. Chem. Rev. 253, 1979–1999.
Fazaeli, Y., Amani, V., Amini, M. M. & Khavasi, H. R. (2010). Acta Cryst. E66, m212. [DOI] [PMC free article] [PubMed]
Freeman, C. D., Klutman, N. E. & Lamp, K. C. (1997). Drugs, 54, 679–708. [DOI] [PubMed]
Galván-Tejada, N., Bernès, S., Castillo-Blum, S. E., Nöth, H., Vicente, R. & Barba-Behrens, N. (2002). J. Inorg. Biochem. 91, 339–348. [DOI] [PubMed]
Johnson, K. & Steed, J. W. (1998). Chem. Commun. pp. 1479–1480.
Lofmark, S., Edlund, C. & Nord, C. E. (2010). Clin. Infect. Dis. 50 (Suppl 1), S16–S23. [DOI] [PubMed]
Miljkovic, V., Arsic, B., Bojanic, Z., Nikolic, G., Nikolic, L. J., Lj, , Kalicanin, B. & Savic, V. (2014). Pharmazie, 69, 571–577. [PubMed]
Nockemann, P., Van Hecke, K., Van Meervelt, L. & Binnemans, K. (2007). Acta Cryst. E63, m402–m404.
Pluzhnik-Gladyr, S. M., Kravtsov, V. C., Fonari, M. S. & Kamalov, G. L. (2014). Dalton Trans. 43, 7087–7095. [DOI] [PubMed]
Samuelson, J. (1999). Antimicrob. Agents Chemother. 43, 1533–1541. [DOI] [PMC free article] [PubMed]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
Soares, G. M. S., Figueiredo, L. C., Faveri, M., Cortelli, S. C., Duarte, P. M. & Feres, M. (2012). J. Appl. Oral Sci. 20, 295–309. [DOI] [PMC free article] [PubMed]
Steiner, T. (2002). Angew. Chem. Int. Ed. 41, 49–76.
Wang, Y.-T., Chu, X.-L., Yan, S.-C. & Tang, G.-M. (2010). Acta Cryst. E66, o2647. [DOI] [PMC free article] [PubMed]
Yang, B. (2008). Acta Cryst. E64, o1338–o1339. [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015010798/lh5766sup1.cif

e-71-00810-sup1.cif^{(658.8KB, cif)}

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015010798/lh5766Isup3.hkl

e-71-00810-Isup3.hkl^{(335.9KB, hkl)}

CCDC reference: 1404845

Additional supporting information: crystallographic information; 3D view; checkCIF report

[bb1] Blaton, N. M., Peeters, O. M. & De Ranter, C. J. (1979). Acta Cryst. B35, 2465–2467.

[bb2] Bruker (2013). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.

[bb3] Contreras, R., Flores-Parra, A., Mijangos, E., Téllez, F., López-Sandoval, H. & Barba-Behrens, N. (2009). Coord. Chem. Rev. 253, 1979–1999.

[bb4] Fazaeli, Y., Amani, V., Amini, M. M. & Khavasi, H. R. (2010). Acta Cryst. E66, m212. [DOI] [PMC free article] [PubMed]

[bb5] Freeman, C. D., Klutman, N. E. & Lamp, K. C. (1997). Drugs, 54, 679–708. [DOI] [PubMed]

[bb6] Galván-Tejada, N., Bernès, S., Castillo-Blum, S. E., Nöth, H., Vicente, R. & Barba-Behrens, N. (2002). J. Inorg. Biochem. 91, 339–348. [DOI] [PubMed]

[bb7] Johnson, K. & Steed, J. W. (1998). Chem. Commun. pp. 1479–1480.

[bb8] Lofmark, S., Edlund, C. & Nord, C. E. (2010). Clin. Infect. Dis. 50 (Suppl 1), S16–S23. [DOI] [PubMed]

[bb9] Miljkovic, V., Arsic, B., Bojanic, Z., Nikolic, G., Nikolic, L. J., Lj, , Kalicanin, B. & Savic, V. (2014). Pharmazie, 69, 571–577. [PubMed]

[bb10] Nockemann, P., Van Hecke, K., Van Meervelt, L. & Binnemans, K. (2007). Acta Cryst. E63, m402–m404.

[bb11] Pluzhnik-Gladyr, S. M., Kravtsov, V. C., Fonari, M. S. & Kamalov, G. L. (2014). Dalton Trans. 43, 7087–7095. [DOI] [PubMed]

[bb12] Samuelson, J. (1999). Antimicrob. Agents Chemother. 43, 1533–1541. [DOI] [PMC free article] [PubMed]

[bb13] Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]

[bb14] Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.

[bb15] Soares, G. M. S., Figueiredo, L. C., Faveri, M., Cortelli, S. C., Duarte, P. M. & Feres, M. (2012). J. Appl. Oral Sci. 20, 295–309. [DOI] [PMC free article] [PubMed]

[bb16] Steiner, T. (2002). Angew. Chem. Int. Ed. 41, 49–76.

[bb17] Wang, Y.-T., Chu, X.-L., Yan, S.-C. & Tang, G.-M. (2010). Acta Cryst. E66, o2647. [DOI] [PMC free article] [PubMed]

[bb18] Yang, B. (2008). Acta Cryst. E64, o1338–o1339. [DOI] [PMC free article] [PubMed]

PERMALINK

Crystal structure of metronidazolium tetrachloridoaurate(III)

Patrick J Quinlivan

Ja-Shin Wu

Rita K Upmacis

Abstract

Chemical context

Structural commentary

Figure 1.

Supramolecular features

Table 1. Hydrogen-bond geometry (, ).

Figure 2.

Database survey

Synthesis and crystallization

Refinement

Table 2. Experimental details.

Supplementary Material

Acknowledgments

supplementary crystallographic information

Crystal data

Data collection

Refinement

Special details

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å²)

Atomic displacement parameters (Å²)

Geometric parameters (Å, º)

Hydrogen-bond geometry (Å, º)

References

Associated Data

Supplementary Materials

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Crystal structure of metronidazolium tetra­chlorido­aurate(III)

Patrick J Quinlivan

Ja-Shin Wu

Rita K Upmacis

Abstract

Chemical context

Structural commentary

Figure 1.

Supra­molecular features

Table 1. Hydrogen-bond geometry (, ).

Figure 2.

Database survey

Synthesis and crystallization

Refinement

Table 2. Experimental details.

Supplementary Material

Acknowledgments

supplementary crystallographic information

Crystal data

Data collection

Refinement

Special details

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

Atomic displacement parameters (Å2)

Geometric parameters (Å, º)

Hydrogen-bond geometry (Å, º)

References

Associated Data

Supplementary Materials

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases

Crystal structure of metronidazolium tetrachloridoaurate(III)

Supramolecular features

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å²)

Atomic displacement parameters (Å²)